Summary of a joint meeting between the Southwest Oncology Group and the Japanese clinical trials consortium.
Rothenberg
M L
ML
Southwest Oncology Group, San Antonio, Texas 78245-3217.
Coltman
C A
CA
Fukushima
M
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000453:epidemiology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007391:International Cooperation; D007564:Japan / Q000453:epidemiology; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000453:epidemiology; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000453:epidemiology; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000453:epidemiology; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000453:epidemiology; D014481:United States / Q000453:epidemiology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000453:epidemiology
D000970:Antineoplastic Agents